| Product Code: ETC9961362 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Bubonic Plague Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Bubonic Plague Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Bubonic Plague Market - Industry Life Cycle |
3.4 United States (US) Bubonic Plague Market - Porter's Five Forces |
3.5 United States (US) Bubonic Plague Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Bubonic Plague Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Bubonic Plague Market Revenues & Volume Share, By End-User, 2021 & 2031F |
3.8 United States (US) Bubonic Plague Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Bubonic Plague Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in global travel leading to potential spread of bubonic plague |
4.2.2 Climate change affecting rodent populations and flea habitats |
4.2.3 Lack of public awareness and education about prevention and treatment of bubonic plague |
4.3 Market Restraints |
4.3.1 Availability of effective antibiotics for treatment |
4.3.2 Stringent regulations and protocols for disease control and prevention |
4.3.3 Negative public perception and stigma associated with bubonic plague |
5 United States (US) Bubonic Plague Market Trends |
6 United States (US) Bubonic Plague Market, By Types |
6.1 United States (US) Bubonic Plague Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Bubonic Plague Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Bubonic Plague Market Revenues & Volume, By Blood Culture, 2021- 2031F |
6.1.4 United States (US) Bubonic Plague Market Revenues & Volume, By Sputum Culture, 2021- 2031F |
6.1.5 United States (US) Bubonic Plague Market Revenues & Volume, By Lymph Node Culture, 2021- 2031F |
6.1.6 United States (US) Bubonic Plague Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.2 United States (US) Bubonic Plague Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Bubonic Plague Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.3 United States (US) Bubonic Plague Market Revenues & Volume, By Vaccines, 2021- 2031F |
6.3 United States (US) Bubonic Plague Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Bubonic Plague Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Bubonic Plague Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4 United States (US) Bubonic Plague Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Bubonic Plague Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) Bubonic Plague Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Bubonic Plague Market Import-Export Trade Statistics |
7.1 United States (US) Bubonic Plague Market Export to Major Countries |
7.2 United States (US) Bubonic Plague Market Imports from Major Countries |
8 United States (US) Bubonic Plague Market Key Performance Indicators |
8.1 Number of reported bubonic plague cases in the US |
8.2 Rate of mortality from bubonic plague |
8.3 Investment in research and development for new treatment methods |
8.4 Public health initiatives and campaigns on bubonic plague prevention and control |
9 United States (US) Bubonic Plague Market - Opportunity Assessment |
9.1 United States (US) Bubonic Plague Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Bubonic Plague Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Bubonic Plague Market Opportunity Assessment, By End-User, 2021 & 2031F |
9.4 United States (US) Bubonic Plague Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Bubonic Plague Market - Competitive Landscape |
10.1 United States (US) Bubonic Plague Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Bubonic Plague Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here